Introduction Conducting a comprehensive Nitrosamine Risk Assessment and Trace-Level NDSRI Testing program is an essential regulatory and quality requirement for […]
Introduction: TTC in Extractables and Leachables (E&L) provides an exposure-based approach for evaluating potential toxicological concerns from low-level chemical substances
Threshold of Toxicological Concern (TTC) in E&L Safety Assessment: A Technical Deep Dive Read More »
Introduction Research-grade peptides and Good Manufacturing Practice (GMP) peptides represent two distinct categories of materials because they are manufactured under
Is Research-Grade Peptide the Same as GMP Peptide? Read More »
Introduction Peptide drugs require specialized cold-chain infrastructure because their dynamic amino acid structures and chemically reactive side chains are highly
Why Do Peptide Drugs Require Cold-Chain Storage and Shipping? Read More »
Reducing the Peptide Cost of Goods for commercial therapeutic drugs requires a comprehensive optimization strategy that addresses high process mass
How Do You Reduce Cost of Goods for a Commercial Peptide Drug? Read More »
Introduction: Immunogenicity testing determines whether a biosimilar monoclonal antibody triggers an unwanted immune response, and regulators require this data to
Introduction The minimum batch size for GMP peptide manufacturing is primarily determined by equipment working volumes, mandatory analytical release testing
What Is the Minimum Batch Size for GMP Peptide Manufacturing? Read More »
Introduction A single qualified contract manufacturing organization can manufacture both active pharmaceutical ingredient (API) drug substance and finished drug product
Can One CDMO Handle Both Peptide API and Finished Drug Product? Read More »
Introduction Essential Peptide CDMO Certifications encompass mandatory regulatory accreditations, including Current Good Manufacturing Practice (cGMP) compliance under ICH Q7 guidelines,
What Certifications and Inspections Should a Peptide CDMO Have? Read More »
Introduction: PLGA and PLA are biodegradable polyester polymers that can be engineered into controlled-release depots — microspheres, nanoparticles, in-situ forming
